{{drugbox
| drug_name = 
| IUPAC_name        = (''RS'')-1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-propanone
| image             = MDPPP.svg
| chirality = [[Racemic mixture]]
| width = 200px
| CAS_number        = 783241-66-7
| ATC_prefix        =
| ATC_suffix        =
| PubChem           = 6430845
| ChemSpiderID = 4936183
| StdInChI = 1S/C14H17NO3/c1-10(15-6-2-3-7-15)14(16)11-4-5-12-13(8-11)18-9-17-12/h4-5,8,10H,2-3,6-7,9H2,1H3
| StdInChIKey = NIYQOTCYXGXMPI-UHFFFAOYSA-N
| DrugBank          =
| C=14 | H=17 | N=1 | O=3
| molecular_weight  = 247.28 g/mol
| smiles            = c3c1OCOc1ccc3C(=O)C(C)N2CCCC2
| bioavailability   =
| protein_bound     =
| metabolism        = Hepatic
| elimination_half-life =
| excretion         = Primarily Urine (Renal)
| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      =  <!-- A / B            / C / D / X -->
| pregnancy_category=
| legal_AU          =  <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA          =  <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK          =  Class A
| legal_US          =  <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_DE          = Anlage I
| routes_of_administration = oral, insufflation, Vaporization, IV, rectal, sublingual 
}}

'''3',4'-Methylenedioxy-α-pyrrolidinopropiophenone''' ('''MDPPP''') is a [[stimulant]] [[designer drug]]. It was sold in Germany in the late 1990s and early 2000s as an ingredient in imitation [[Methylenedioxymethamphetamine|ecstasy (MDMA)]] pills.<ref name="Fritschi" /> It shares a similar chemical structure with [[Alpha-Pyrrolidinopropiophenone|α-PPP]] and [[Methylenedioxypyrovalerone|MDPV]],<ref name="Maurer" /><ref name="Staack" /><ref name="Springer" /> and has been shown to have reinforcing effects in rats.<ref>{{cite journal|last1=Gannon|first1=BM|last2=Galindo|first2=KI|last3=Mesmin|first3=MP|last4=Sulima|first4=A|last5=Rice|first5=KC|last6=Collins|first6=GT|title=Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats.|journal=Neuropharmacology|date=12 August 2017|doi=10.1016/j.neuropharm.2017.08.018|pmid=28811192}}</ref> 

==Metabolism==
MDPPP appears to have a similar metabolic fate as [[MDPV]].<ref name="Springer" />

==Legal Status==

As of October 2015 MDPPP is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>

==See also==
* [[α-Pyrrolidinopropiophenone]] (α-PPP)
* [[4'-Methyl-α-pyrrolidinopropiophenone]] (MPPP)
* [[4'-Methoxy-α-pyrrolidinopropiophenone]] (MOPPP)
* [[3',4'-Methylenedioxy-α-pyrrolidinobutiophenone]] (MDPBP)

== References ==

{{Reflist|refs=

<ref name="Fritschi">{{Cite journal | last1 = Springer | first1 = D. | last2 = Fritschi | first2 = G. | last3 = Maurer | first3 = H. H. | doi = 10.1016/S1570-0232(03)00350-7 | title = Metabolism and toxicological detection of the new designer drug 3′,4′-methylenedioxy-α-pyrrolidinopropiophenone studied in urine using gas chromatography–mass spectrometry | journal = Journal of Chromatography B | volume = 793 | issue = 2 | pages = 377 | year = 2003 | pmid =  | pmc = }}</ref>

<ref name="Maurer">{{cite journal | last1 = Maurer | first1 = HH | last2 = Kraemer | first2 = T | last3 = Springer | first3 = D | last4 = Staack | first4 = RF | title = Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis | journal = Therapeutic drug monitoring | volume = 26 | issue = 2 | pages = 127–31 | year = 2004 | pmid = 15228152 | doi = 10.1097/00007691-200404000-00007 }}</ref>

<ref name="Staack">{{cite journal | last1 = Staack | first1 = RF | last2 = Maurer | first2 = HH | title = Metabolism of designer drugs of abuse | journal = Current drug metabolism | volume = 6 | issue = 3 | pages = 259–74 | year = 2005 | pmid = 15975043 | doi = 10.2174/1389200054021825 }}</ref>

<ref name="Springer">{{cite journal | last1 = Springer | first1 = D | last2 = Staack | first2 = RF | last3 = Paul | first3 = LD | last4 = Kraemer | first4 = T | last5 = Maurer | first5 = HH | title = Identification of cytochrome P450 enzymes involved in the metabolism of 3',4'-methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP), a designer drug, in human liver microsomes | journal = Xenobiotica | volume = 35 | issue = 3 | pages = 227–37 | year = 2005 | pmid = 16019948 | doi = 10.1080/00498250400028239 }}</ref>

}}

{{Stimulants}}
{{Adrenergics}}
{{Dopaminergics}}
{{MDxx}}

{{DEFAULTSORT:Methylenedioxy-A-Pyrrolidinopropiophenone, 3',4'-}}
[[Category:Designer drugs]]
[[Category:Pyrrolidinophenones]]
[[Category:Benzodioxoles]]


{{nervous-system-drug-stub}}